# Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age

> **NCT00463684** · PHASE4 · COMPLETED · sponsor: **PATH** · enrollment: 278 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine
- **BIOLOGICAL:** Live, attenuated measles vaccine

## Key facts

- **NCT ID:** NCT00463684
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07-07
- **Primary completion:** 2007-11-07
- **Final completion:** 2008-10-06
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2019-02-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463684, "Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00463684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*